A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits. [electronic resource]
Producer: 20190604Description: 34-42 p. digitalISSN:- 1873-2747
- Alzheimer Disease -- drug therapy
- Amyloid beta-Peptides -- metabolism
- Animals
- Antioxidants -- pharmacology
- Bucladesine -- pharmacology
- Cyclic AMP -- analogs & derivatives
- Disease Models, Animal
- Hippocampus -- drug effects
- Male
- Maze Learning -- drug effects
- Memory Disorders -- drug therapy
- Mitochondria -- drug effects
- Mitochondrial Diseases -- drug therapy
- Neuroprotective Agents -- pharmacology
- Nootropic Agents -- pharmacology
- Oxidative Stress -- drug effects
- Peptide Fragments -- metabolism
- Rats, Wistar
- Spatial Memory -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.